Irbesartan monotherapy

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Hypertension

Phase 3

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension

CompletedNCT00095394

Bristol-Myers SquibbHypertension

Start: 2004-09-30End: 2005-05-31Target: 645Updated: 2011-04-15

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension

CompletedNCT00095550

Bristol-Myers SquibbHypertension

Start: 2004-10-31End: 2005-06-30Target: 496Updated: 2011-04-15